- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage IV Melanoma in Australia
Total 461 results
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Idera Pharmaceuticals, Inc.Bristol-Myers SquibbTerminatedMetastatic MelanomaUnited States, Canada, Spain, United Kingdom, France, Australia, Germany, Italy, Netherlands, Sweden, Czechia
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia
-
Eisai Inc.CompletedMetastatic MelanomaUnited States, Australia, United Kingdom, Germany
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Spain, United Kingdom, Belgium, Australia, Poland, Germany, Netherlands, Slovenia, Italy, Switzerland, Israel, Bulgaria, Croatia, Czech Republic, Estonia, Portugal, Turkey
-
TakedaCompletedMelanoma | NeoplasmsUnited States, Australia
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.Active, not recruitingMetastatic MelanomaItaly, Germany, Spain, Greece, Austria, France, Poland, Sweden, Switzerland, United Kingdom
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
Novartis PharmaceuticalsRecruitingMetastatic Uveal MelanomaUnited States, Australia, France, Netherlands, Switzerland, Germany, Spain
-
GlaxoSmithKlineCompletedMelanomaAustralia, United States
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Norway, Belgium, United Kingdom, Germany, Austria, Portugal, Italy
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Belgium, Finland, Austria, Ireland, Sweden, Switzerland, United Kingdom, Germany, Norway
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
Eucure (Beijing) Biopharma Co., LtdWithdrawnHCC | NSCLC Stage IV | NSCLC Stage IIIBChina, Australia, Taiwan, Armenia, Austria
-
CelgeneICON Clinical ResearchCompletedMelanoma | Neoplasm MetastasisAustralia, United Kingdom, Ukraine, Germany, Estonia, Latvia, Lithuania, Netherlands, South Africa
-
OnxeoCompletedMelanomaAustria, France, Germany, Switzerland
-
IDEAYA BiosciencesRecruitingUveal MelanomaUnited States, Australia, Canada, Netherlands, Italy, France, Germany, United Kingdom
-
GlaxoSmithKlineCompletedMelanomaAustralia, France, Germany, United States, Italy
-
PfizerTerminatedMetastatic Pancreatic Adenocarcinoma | BRAF Mutated MelanomaUnited States, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
-
Genentech, Inc.BioNTech SEActive, not recruitingAdvanced MelanomaUnited States, Spain, Belgium, Australia, Germany, United Kingdom
-
Bristol-Myers SquibbCompletedAdvanced Cutaneous MelanomaGermany, Poland, Spain, Australia, France, Argentina, Ireland, Israel, Belgium, United States, Switzerland, United Kingdom, Greece, Austria, Canada
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
ModernaTX, Inc.Merck Sharp & Dohme LLCRecruiting
-
Columbia UniversityRecruitingUveal MelanomaUnited States, Australia, Canada, Germany, United Kingdom
-
Mural Oncology, IncRecruitingCutaneous Melanoma | Mucosal MelanomaUnited States, Australia, Canada, Italy, Korea, Republic of, Spain, Taiwan, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Agenus Inc.Terminated
-
Array BioPharmaTerminatedMelanomaCanada, Spain, Australia, Switzerland, Germany, United States
-
Queensland Centre for Gynaecological CancerRoyal Brisbane and Women's Hospital; The University of QueenslandCompletedOvarian Cancer Stage IV | Ovarian Cancer Stage IIIAustralia
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Germany, Belgium, Netherlands, United Kingdom, Italy, Portugal, Austria
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Aura BiosciencesRecruitingOcular Melanoma | Uveal Melanoma | Choroidal Melanoma | Indeterminate LesionsUnited States, Australia, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaItaly, United Kingdom, Belgium, Poland, Netherlands, Germany, Austria, Czechia, Ireland, Sweden
-
Hoffmann-La RocheTerminatedAdvanced BRAFV600 Wild-type MelanomaUnited States, Korea, Republic of, Australia, Belgium, France, Russian Federation, Italy, Netherlands, Spain, United Kingdom, Brazil, Poland, Germany, Greece, Hungary
-
AstraZenecaCompletedMelanomaUnited States, Australia, Brazil, United Kingdom, Argentina, Austria, Canada, Denmark, France, Switzerland
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
GlaxoSmithKlineTerminatedMelanoma and Brain MetastasesUnited States, Australia
-
PlexxikonRoche Pharma AGCompletedColorectal Carcinoma | Malignant MelanomaUnited States, Australia
-
Incyte CorporationActive, not recruiting
-
Bristol-Myers SquibbCompletedMelanomaItaly, France, Spain, Australia
-
European Organisation for Research and Treatment...TerminatedMetastatic Cancer | Melanoma (Skin)France, Norway, Belgium, Netherlands, United Kingdom, Austria, Czech Republic, Germany, Italy, Portugal, Switzerland
-
GlaxoSmithKlineCompletedMelanomaUnited States, Italy, United Kingdom, France, Sweden, Germany, Poland, Australia, Belgium, Austria, Canada, Czechia, Greece, Russian Federation, Ukraine, Norway, Switzerland, New Zealand, Argentina
-
Bristol-Myers SquibbWithdrawnMelanomaFrance, Italy, Poland, United States, Brazil, Spain, Australia, Denmark, Germany, Austria, Netherlands, Russian Federation, Belgium, United Kingdom, Sweden, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedStage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7 | Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7 | Stage II Nasopharyngeal Keratinizing... and other conditionsUnited States, Canada, Australia
-
IDEAYA BiosciencesRecruitingMetastatic Uveal MelanomaUnited States, Canada, Israel, Spain, Australia, Germany, France, Italy, United Kingdom, Netherlands, Belgium, Poland, Switzerland
-
Bristol-Myers SquibbCompletedUnresectable or Metastatic MelanomaUnited States, Germany, Italy, United Kingdom, Canada, Denmark, Netherlands, Spain, Belgium, France, Switzerland, Israel, Austria, Brazil